Steven A. Carr

Steven A. Carr

Broad Institute of MIT and Harvard

Affiliated withBroad Institute of MIT and Harvard

Research Area

Biography

Steven A. Carr has not added Biography.
If you are Steven A. Carr and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Publication title

Cited by 37

2011

Other Publications

Article
Year
Mass spectrometry-based methods for phosphorylation site mapping of hyperphosphorylated proteins applied to Net1, a regulator of exit from mitosis in yeast.

Molecular & cellular proteomics : MCP| PubMed ID: 12096118

2002
2002
2002
2004
2004
2004
Place of pattern in proteomic biomarker discovery.

Journal of proteome research| PubMed ID: 16083265

2005
2005
2006
PEPPeR, a platform for experimental proteomic pattern recognition.

Molecular & cellular proteomics : MCP| PubMed ID: 16857664

2006
2006
2006
2006
2007
2007
2007
2008
2008
2008
2008
2008
2009
A human proteome detection and quantitation project.

Molecular & cellular proteomics : MCP| PubMed ID: 19131327

2009
2009
Identifying the proteins to which small-molecule probes and drugs bind in cells.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19255428

2009
2009
2009
2009
2009
2009
2009
2009
2010
2010
2010
2010
2010
2010
2009
2010
2010
2010
Optimizing performance of glycopeptide capture for plasma proteomics.

Journal of proteome research| PubMed ID: 20235580

2010
2010
Metabolic signatures of exercise in human plasma.

Science translational medicine| PubMed ID: 20505214

2010
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20616024

2010
2010
2010
Overview of peptide and protein analysis by mass spectrometry.

Current protocols in protein science / editorial board, John E. Coligan ... [et al.]| PubMed ID: 21104985

2010
2011
2011
2011
2011
2011
2011
2011
2011
2011
2012
2011
2011
2011
2011
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 22323609

2012